Clinical feasibility test on a minimally invasive laser therapy system in microsurgery of nerves

The clinical feasibility test described here evaluates the basis for a laser therapy system that enables tumour tissue to be separated from nerves in a minimally invasive manner. It was first investigated whether, using an Er:YAG laser, laser‐induced nerve (specifically, facial nerve) responses in the rabbit in vivo can be reliably detected with the hitherto standard monitoring techniques. Peripherally recordable neuromuscular signals (i.e. compound action potentials, CAPs) were used to monitor nerve function and to establish a feedback loop. The first occurrence of laser‐evoked CAPs was taken as the criterion for deciding when to switch off the laser. When drawing up criteria governing the control and termination of the laser application, the priority was the maintenance of nerve function. Five needle‐electrode arrays specially developed for this purpose, each with a miniature preamplifier, were then placed into the facial musculature instead of single‐needle electrodes. The system was tested in vivo under realistic surgical conditions (i.e. facial‐nerve surgery in the rabbit). This modified multi‐channel electromyography (EMG) system enabled laser‐evoked CAPs to be detected that have amplitudes 10 times smaller than those picked up by commercially available systems. This optimization, and the connection of the neuromuscular unit with the Er:YAG laser via the electrode array to create a feedback loop, were designed to make it possible to maintain online control of the laser ablation process in the vicinity of neuronal tissue, thus ensuring that tissue excision is both reliable and does not affect function.

Our results open up new possibilities in minimally invasive surgery near neural structures.